Fundraising Fox
TripleBar Bio, Inc.
Emeryville, US · Founded 2019 · Delaware corporation · 12 employees on LinkedIn · 5 known investors
Find your way into TripleBar Bio, Inc.
Sign up to see every warm intro you have to TripleBar Bio, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TripleBar Bio, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
Founders & leadership
TripleBar Bio, Inc. was founded in 2019 by Jeremy Agresti.
Board
Investors · 5
How we know: iSelect Fund's portfolio page · Not right? Tell us
How we know: Rabo Corporate Venturing's portfolio page · Not right? Tell us
How we know: Stray Dog Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.8M disclosed across 1 round · 2023
▶$19.8MraisedOct 2023 · 9 investors · BiotechnologyRule 506(b)
- Rose WardleDirector
- Howard LevinDirector
- David FriedbergDirector
- Maria ChoExecutive Officer, Director
- Offering amount
- $20.5M
- Amount sold
- $19.8M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as TripleBar Bio, Inc..
Frequently asked questions
- What does TripleBar Bio, Inc. do?
- Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
- Who founded TripleBar Bio, Inc.?
- TripleBar Bio, Inc. was founded by Jeremy Agresti in 2019.
- Who are TripleBar Bio, Inc.'s investors?
- TripleBar Bio, Inc.'s investors include iSelect Fund, Rabo Corporate Venturing, Stray Dog Capital, Synthesis Capital, TPB.
- How much funding has TripleBar Bio, Inc. raised?
- TripleBar Bio, Inc. has disclosed $19.8M raised across 1 round.
- Where is TripleBar Bio, Inc. headquartered?
- TripleBar Bio, Inc. is headquartered in Emeryville, US.